Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alok R Amraotkar

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Texas Heart Institute Journal|April 30, 2016
Rapid Extracorporeal Membrane Oxygenation Overcomes Fulminant Myocarditis Induced by 5‑FluorouracilAlok R Amraotkar, Ajay Pachika, Kendra J Grubb, et al.
Frontiers in Cardiovascular Medicine|August 22, 2017
Circulating Prolidase Activity in Patients with Myocardial InfarctionAdnan Sultan, Yuting Zheng, Patrick J Trainor, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 7, 2025
Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trialTimothy E O'Toole, Alok R Amraotkar, Hong Gao, et al.
Stem Cells (Dayton, Ohio)|August 10, 2016
The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent MechanismJoseph B Moore, John Zhao, Matthew C L Keith, et al.
Journal of the International Society of Sports Nutrition|June 17, 2026
Effects of carnosine supplementation on physical endurance: a placebo-controlled randomized clinical trialTimothy E O'Toole, Christopher J Wingard, Sonja K Bariess, et al.
Cardiology Journal|February 3, 2017
Presence of multiple coronary angiographic characteristics for the diagnosis of acute coronary thrombusAlok R Amraotkar, Shahab Ghafghazi, Patrick J Trainor, et al.
Cureus|September 5, 2019
Outcomes and Predictors of Mortality in Hospitalized Frail Patients Undergoing Percutaneous Coronary InterventionRupak Desai, Alok R Amraotkar, Melissa G Amraotkar, et al.
Vaccines|August 26, 2022
Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 VaccinationAlok R Amraotkar, Adrienne M Bushau-Sprinkle, Rachel J Keith, et al.
American Journal of Preventive Cardiology|June 15, 2026
Enhancing representation in cardiovascular trials: Lessons from Lp(a)FRONTIERS EXPANSION in United States Black and Hispanic patients with elevated lipoprotein(a) and established atherosclerotic cardiovascular diseaseKeith C Ferdinand, Fatima Rodriguez, Alok R Amraotkar, et al.
Plos One|April 18, 2017
Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery diseaseAndrew P DeFilippis, Patrick J Trainor, Bradford G Hill, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Texas Heart Institute Journal|April 30, 2016
Rapid Extracorporeal Membrane Oxygenation Overcomes Fulminant Myocarditis Induced by 5‑FluorouracilAlok R Amraotkar, Ajay Pachika, Kendra J Grubb, et al.
Frontiers in Cardiovascular Medicine|August 22, 2017
Circulating Prolidase Activity in Patients with Myocardial InfarctionAdnan Sultan, Yuting Zheng, Patrick J Trainor, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 7, 2025
Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trialTimothy E O'Toole, Alok R Amraotkar, Hong Gao, et al.
Stem Cells (Dayton, Ohio)|August 10, 2016
The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent MechanismJoseph B Moore, John Zhao, Matthew C L Keith, et al.
Journal of the International Society of Sports Nutrition|June 17, 2026
Effects of carnosine supplementation on physical endurance: a placebo-controlled randomized clinical trialTimothy E O'Toole, Christopher J Wingard, Sonja K Bariess, et al.
Cardiology Journal|February 3, 2017
Presence of multiple coronary angiographic characteristics for the diagnosis of acute coronary thrombusAlok R Amraotkar, Shahab Ghafghazi, Patrick J Trainor, et al.
Cureus|September 5, 2019
Outcomes and Predictors of Mortality in Hospitalized Frail Patients Undergoing Percutaneous Coronary InterventionRupak Desai, Alok R Amraotkar, Melissa G Amraotkar, et al.
Vaccines|August 26, 2022
Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 VaccinationAlok R Amraotkar, Adrienne M Bushau-Sprinkle, Rachel J Keith, et al.
American Journal of Preventive Cardiology|June 15, 2026
Enhancing representation in cardiovascular trials: Lessons from Lp(a)FRONTIERS EXPANSION in United States Black and Hispanic patients with elevated lipoprotein(a) and established atherosclerotic cardiovascular diseaseKeith C Ferdinand, Fatima Rodriguez, Alok R Amraotkar, et al.
Plos One|April 18, 2017
Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery diseaseAndrew P DeFilippis, Patrick J Trainor, Bradford G Hill, et al.
Pageof 3